Dolev Rafaeli Net Worth

The estimated Net Worth of Dolev Rafaeli is at least $808 mil dollars as of 15 July 2024. Dolev Rafaeli owns over 19,100 units of STRATA Skin Sciences Inc stock worth over $457,383 and over the last 10 years he sold SSKN stock worth over $350,208. In addition, he makes $0 as Interim Chief Executive Officer at STRATA Skin Sciences Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Dolev Rafaeli SSKN stock SEC Form 4 insiders trading

Dolev has made over 14 trades of the STRATA Skin Sciences Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently he bought 19,100 units of SSKN stock worth $59,974 on 15 July 2024.

The largest trade he's ever made was selling 150,000 units of STRATA Skin Sciences Inc stock on 21 December 2015 worth over $46,500. On average, Dolev trades about 37,529 units every 161 days since 2015. As of 15 July 2024 he still owns at least 143,156 units of STRATA Skin Sciences Inc stock.

You can see the complete history of Dolev Rafaeli stock trades at the bottom of the page.

Dolev Rafaeli biography

Dr. Dolev Rafaeli has been appointed as an Interim Chief Executive Officer of the Company, with effect from April 10, 2018. Dr. Dolev Rafaeli has over 25 years of experience in the healthcare, medical device, consumer and industrial services fields. He served as a Member of the Board of Directors of the company that founded the XTRAC, PhotoMedex (Nasdaq:PHMD), since 2011 and was its CEO from 2006 to 2015. Under his management at PhotoMedex, he oversaw sales growth from $19 million to over $300 million, driven by increases in brand portfolio, distribution channels and M&A transactions. He was President and CEO of Radiancy, a subsidiary of PhotoMedex, from 2006 to 2017.

What's Dolev Rafaeli's mailing address?

Dolev's mailing address filed with the SEC is C/O STRATA SKIN SCIENCES, INC., 5 WALNUT GROVE DRIVE, STE. 140, HORSHAM, PA, 19044.

Insiders trading at STRATA Skin Sciences Inc

Over the last 9 years, insiders at STRATA Skin Sciences Inc have traded over $348,780 worth of STRATA Skin Sciences Inc stock and bought 2,664,087 units worth $2,970,754 . The most active insiders traders include Healthcare Master Fund Ltd ..., Lp22 Nw Fund, Lp22 Nw Fund ... y Dolev Rafaeli. On average, STRATA Skin Sciences Inc executives and independent directors trade stock every 127 days with the average trade being worth of $392,199. The most recent stock trade was executed by Uri Geiger on 15 July 2024, trading 230,573 units of SSKN stock currently worth $723,999.

What does STRATA Skin Sciences Inc do?

formerly mela sciences, strata skin sciences is a new company built by unconventional thinkers. a medical technology company that brings hope and help to the dermatology patient in all of us. it’s not just a device or a technology, it’s optimism for psoriasis, determination for improving patients’ lives, and advocacy for getting it right.

Complete history of Dolev Rafaeli stock trades at STRATA Skin Sciences Inc

STRATA Skin Sciences Inc executives and stock owners

STRATA Skin Sciences Inc executives and other stock owners filed with the SEC include:

• Michael R. Stewart,
  Independent Consultant
• Kathryn Swintek,
  Independent Director
• David Stone,
  Independent Director
• Samuel Navarro,
  Independent Director
• Jeffrey O'Donnell,
  Director
• James Coyne,
  Director
• Matthew Hill,
  Chief Financial Officer
• Dolev Rafaeli,
  Interim Chief Executive Officer
• Frank McCaney,
  President, Director
• LuAnn Via,
  Chairman of the Board
• Nikolai Kabelev,
  VP of R&D
• Shmuel Gov,
  Exec. VP & GM
• Dr. Darrell S. Rigel,
  Chief Medical Advisor
• Keith Simeone,
  VP of Sales
• Jay Sturm,
  Gen. Counsel & Corp. Sec.
• Christopher Lesovitz,
  Chief Financial Officer
• Robert J. Moccia,
  Pres, CEO & Director
• William D. Humphries,
  Exec. Chairman
• Healthcare Master Fund Ltd ...,
  
• Michael R Stewart,
  President & CEO
• Richard Rox Anderson,
  Director
• Christina L Allgeier,
  CFO
• David N Gill,
  
• Partners, L.P.Accelmed Part...,
  
• Douglas Strang,
  
• Samuel Rubinstein,
  
• Nachum Shamir,
  
• Christopher Lesovitz,
  Chief Financial Officer
• William D. Humphries,
  
• Uri Geiger,
  Director
• Wayne Cafran,
  
• Irit Yaniv,
  
• Patricia S Walker,
  
• Robert Joseph Moccia,
  Chief Executive Officer
• Lp22 Nw Fund, Lp22 Nw Fund ...,
  
• Shmuel Gov,
  COO